Brian William Dymock
27Patents
6h-index
39Co-inventors
65Inventor score
Filing activity: Jun 13, 2001 → Jul 31, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7612201B2 | Pyrazole compounds | Chemistry; Metallurgy | 28 | Expired |
| US7632855B2 | Pyrazole compounds as HSP90 inhibitors for the treatment of cancer | Chemistry; Metallurgy | 26 | Expired |
| US7189718B2 | Non-nucleoside reverse transcriptase inhibitors | Chemistry; Metallurgy | 15 | Expired |
| US7247734B2 | 3,4-diarylpyrazoles and their use in the therapy of cancer | Chemistry; Metallurgy | 14 | Expired |
| US6538015B1 | Anti-HIV pyrazole derivatives | Chemistry; Metallurgy | 8 | Expired |
| US8507480B2 | Isoxazole compounds as inhibitors of heat shock proteins | Chemistry; Metallurgy | 7 | Active |
| US7705027B2 | Isoxazole compounds as inhibitors of heat shock proteins | Chemistry; Metallurgy | 6 | Expired |
| US7820658B2 | Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors | Human Necessities | 4 | Expired |
| US8450310B2 | Isoxazole compounds as inhibitors of heat shock proteins | Chemistry; Metallurgy | 4 | Active |
| US9120815B2 | Solid state forms of macrocyclic kinase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US9718793B2 | Isoxazole compounds as inhibitors of heat shock proteins | Chemistry; Metallurgy | 2 | Active |
| US8642594B2 | Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors | Human Necessities | 2 | Active |
| US7803831B2 | 3-(2-hydroxy-phenyl)-1H-pyrazole-4-carboxylic acid amide derivatives as HSP90 inhibitors for the treatment of cancer | Chemistry; Metallurgy | 2 | Active |
| US8980873B2 | 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt | Chemistry; Metallurgy | 1 | Active |
| US6737429B2 | Pyrrole derivatives | Chemistry; Metallurgy | 1 | Expired |
| US10413550B2 | Isoxazole compounds as inhibitors of heat shock proteins | Chemistry; Metallurgy | 1 | Active |
| US7728016B2 | Substituted 5-membered ring compounds and their use | Human Necessities | 1 | Expired |
| US9062074B2 | (9E)-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza-tetracyclo[18.3.1.1(2.5).1(14,18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt | Human Necessities | 0 | Active |
| US8163747B2 | Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms | Chemistry; Metallurgy | 0 | Active |
| US8987243B2 | 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-maleate salt | Human Necessities | 0 | Active |
| US8487095B2 | Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-iso-propyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms | Chemistry; Metallurgy | 0 | Active |
| US10308631B2 | Selective anti-cancer compounds | Chemistry; Metallurgy | 0 | Active |
| US6699887B2 | Anti-HIV pyrazole derivatives | Chemistry; Metallurgy | 0 | Expired |
| US6518293B2 | Anti-HIV imidazolone derivatives | Chemistry; Metallurgy | 0 | Expired |
| US11234987B2 | Isoxazole compounds as inhibitors of heat shock proteins | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.